{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:40:33Z","timestamp":1769640033401,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.maturitas.2015.11.003","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T03:50:47Z","timestamp":1447127447000},"page":"94-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["EMAS position statement: Testosterone replacement therapy in the aging male\u200f"],"prefix":"10.1016","volume":"84","author":[{"given":"Christina","family":"Dimopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iuliana","family":"Ceausu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Depypere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Lambrinoudaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Mueck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faustino R.","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne T.","family":"van der Schouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent M.","family":"Senturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Simonsini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Stute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2015.11.003_bib0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.278.5337.419","article-title":"The endocrinology of aging","volume":"5337","author":"Lamberts","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1210\/jc.2013-3570","article-title":"Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011","volume":"99","author":"Layton","year":"2014","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.beem.2014.09.008","article-title":"Current topics in testosterone replacement of hypogonadal men","volume":"29","author":"Nieschlag","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","article-title":"Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal resultsfrom the Massachusetts male aging study","volume":"87","author":"Feldman","year":"2002","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.maturitas.2010.07.011","article-title":"Androgens, health and sexuality in women and men","volume":"67","author":"Wylie","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000184233","article-title":"Ageing of the hypothalamo\u2013pituitary\u2013testicular axis in men","volume":"43","author":"Vermeulen","year":"1995","journal-title":"Horm. Res."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0035","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2011-2513","article-title":"Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS)","volume":"97","author":"Tajar","year":"2012","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/13685538.2015.1004049","article-title":"Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men","volume":"18","author":"Lunenfeld","year":"2015","journal-title":"Aging Male"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.maturitas.2009.04.004","article-title":"Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men","volume":"63","author":"Blumel","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/humupd\/dmh035","article-title":"Testosterone replacement therapy: current trends and future directions","volume":"10","author":"Nieschlag","year":"2004","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of late-onset hypogonadism in middle-aged and elderly men","volume":"363","author":"Wu","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-7525-1-15","article-title":"The Aging Males\u2019 Symptoms (AMS) scale: update and compilation of international versions","volume":"1","author":"Heinemann","year":"2003","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0065","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/EJE-08-0601","article-title":"Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations","volume":"159","author":"Wang","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0070","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0075","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2004-0143","article-title":"Blood testosterone threshold for androgen deficiency symptoms","volume":"89","author":"Kelleher","year":"2004","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0080","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2006-0401","article-title":"Association of specific symptoms and metabolic risks with serum testosterone in older men","volume":"91","author":"Zitzmann","year":"2006","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0085","doi-asserted-by":"crossref","DOI":"10.3109\/13685538.2011.650246","article-title":"Diagnosing and treating testosterone deficiency in different parts of the world: changes between 2006 and 2010","volume":"15","author":"Gooren","year":"2012","journal-title":"Aging Male"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0090","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1206168","article-title":"Gonadal steroids and body composition, strength, and sexual function in men","volume":"369","author":"Finkelstein","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/1008-682X.122586","article-title":"The relationship between sleep disorders and testosterone in men","volume":"16","author":"Wittert","year":"2014","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0100","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2337\/dc10-2339","article-title":"Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes","volume":"34","author":"Wang","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0105","doi-asserted-by":"crossref","first-page":"e000272","DOI":"10.1161\/JAHA.113.000272","article-title":"Testosterone and the cardiovascular system: a comprehensive review of the clinical literature","volume":"2","author":"Oskui","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0110","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1530\/JOE-13-0393","article-title":"Testosterone and glucose metabolism in men: current concepts and controversies","volume":"220","author":"Grossmann","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0115","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2013-2052","article-title":"Late-onset hypogonadism and mortality in aging men","volume":"99","author":"Pye","year":"2014","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0120","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1210\/jc.2011-1137","article-title":"Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis","volume":"96","author":"Araujo","year":"2011","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0125","unstructured":"S. Bhasin, G. Huang, T.G. Travison, et al., Age-Related Changes in the Male Reproductive Axis, [Updated 2014 Feb 14]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc., 2000. Available from: http:\/\/www.ncbi.nlm.nih.gov\/%20books\/NBK278998\/."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0130","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMclde1406595","article-title":"Clinical decisions. Testosterone-replacement therapy","volume":"371","author":"Swerdloff","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5 Suppl","key":"10.1016\/j.maturitas.2015.11.003_bib0135","first-page":"S83","article-title":"Androgen deficiency in the aging male","volume":"90","author":"Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Male Reproduction and Urology","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2007.51","article-title":"Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial","volume":"299","author":"Emmelot-Vonk","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0145","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1210\/jc.2013-1970","article-title":"Beneficial and adverse effects of testosterone on the cardiovascular system in men","volume":"98","author":"Ruige","year":"2013","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0150","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-13-0321","article-title":"Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes","volume":"169","author":"Muraleedharan","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0155","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc10-1233","article-title":"Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES2 study)","volume":"34","author":"Jones","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0160","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/jsm.12146","article-title":"Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes","volume":"10","author":"Hackett","year":"2013","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/ijcp.12235","article-title":"The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study)","volume":"68","author":"Hackett","year":"2014","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0170","article-title":"Guidelines on male hypogonadism","author":"Dohle","year":"2012","journal-title":"Eur. Assoc. Urol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0175","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2010-3012","article-title":"Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham heart study and applied to three geographically distinct cohorts","volume":"96","author":"Bhasin","year":"2011","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0180","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2265.2012.04432.x","article-title":"Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study","volume":"77","author":"Sartorius","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0185","doi-asserted-by":"crossref","first-page":"983e91","DOI":"10.1530\/EJE-11-1051","article-title":"Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men","volume":"166","author":"Huhtaniemi","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0190","doi-asserted-by":"crossref","DOI":"10.1111\/cen.12042","article-title":"Similar reference intervals for total testosterone in healthy young and elderly men: results from the Odense androgen study","volume":"78","author":"Frost","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0195","series-title":"Testosterone: Action, Deficiency, Substitution","first-page":"60e86","article-title":"Methodology for measuring testosterone, dihydrotestosterone and sex hormonebinding globulin in a clinical setting","author":"Simoni","year":"2012"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0200","doi-asserted-by":"crossref","first-page":"161e8","DOI":"10.4103\/1008-682X.122358","article-title":"Testosterone deficiency: a historical perspective","volume":"16","author":"Nieschlag","year":"2014","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0205","series-title":"Guidelines for the Use of Androgens","year":"1992"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0210","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1158\/1055-9965.EPI-04-0715","article-title":"Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy","volume":"14","author":"Parsons","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0215","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamainternmed.2015.1573","article-title":"Comparative safety of testosterone dosage forms","volume":"175","author":"Layton","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0220","first-page":"265","article-title":"Induction of insulin resistance by androgens and estrogens","volume":"79","author":"Polderman","year":"1994","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0225","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0230","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1210\/jc.2004-0807","article-title":"The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations","volume":"89","author":"Liu","year":"2004","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0235","doi-asserted-by":"crossref","first-page":"e85805","DOI":"10.1371\/journal.pone.0085805","article-title":"Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men","volume":"9","author":"Finkle","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0240","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0245","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0250","unstructured":"Food and Drug Asministration (FDA) http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm436280.htm. (assessed on 05.10.15)."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0255","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/jc.2011-2591","article-title":"Testosterone treatment and mortality in men with low testosterone levels","volume":"97","author":"Shores","year":"2012","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0260","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S2213-8587(14)70082-8","article-title":"Testosterone, cardiovascular disease, and mortality in men: living in the dark","volume":"2","author":"Page","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0265","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.4158\/EP14434.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the association of testosterone and cardiovascular risk","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0270","unstructured":"European Medicines Agency (EMAS), http:\/\/www.ema.europa.eu\/ema\/%20index.jsp?curl=pages\/medicines\/human\/referrals\/Testosteronecontaining_medicines\/human_referral_prac_000037.jsp&mid=WC0b01ac0%205805516f%29) (assessed on 05.10.15)."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0275","unstructured":"The Endocrine Society. The risk of cardiovascular events in men receiving testosterone therapy: an Endocrine Society statement. February 7, 2014 (https:\/\/www.endocrine.org\/%E2%88%BC\/media\/endosociety\/Files\/Advocacy%20and%20Outreach\/%20Position%20Statements\/Other%20Statements\/%20The%20Risk%20of%20Cardiovascular%20Events%20in%20Men%20Receiving%20Testosterone%20Therapy.pdf)."},{"issue":"Suppl","key":"10.1016\/j.maturitas.2015.11.003_bib0280","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0025-6196(19)30648-2","article-title":"Experience with testosterone replacement in the elderly","volume":"75","author":"Tenover","year":"2000","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0285","doi-asserted-by":"crossref","unstructured":"Report of National Institute on Aging advisory panel on testosterone replacement in men, J. Clin. Endocrinol. Metabol. 86 (2001) 461\u2013464.","DOI":"10.1210\/jcem.86.10.7942"},{"key":"10.1016\/j.maturitas.2015.11.003_bib0290","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2265.1985.tb00161.x","article-title":"Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleep","volume":"22","author":"Matsumoto","year":"1985","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0295","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1743-6109.2007.00553.x","article-title":"Testosterone therapy and obstructive sleep apnea: is there a real connection?","volume":"4","author":"Hanafy","year":"2007","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.maturitas.2015.11.003_bib0300","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis","volume":"95","author":"Fern\u00e1ndez-Balsells","year":"2010","journal-title":"J. Clin. Endocrinol. Metabol."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512215008087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512215008087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:05:49Z","timestamp":1759914349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512215008087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":60,"alternative-id":["S0378512215008087"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2015.11.003","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EMAS position statement: Testosterone replacement therapy in the aging male\u200f","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2015.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}